센스오닉스 홀딩스(SENS)는 NAS에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $9.58 (+1.59%), 시가총액 $306.17M.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc.
센스오닉스 홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
센스오닉스 홀딩스의 현재 주가는 $9.58 (+1.59%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
센스오닉스 홀딩스의 시가총액은 약 $306.17M입니다.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the…